<ARTICLE> 5
<CIK> 0000830656
<NAME> BOSTON BIOMEDICA

                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         260,273
<SECURITIES>                                         0
<RECEIVABLES>                                7,120,606
<ALLOWANCES>                                 (785,036)
<INVENTORY>                                  7,547,377
<CURRENT-ASSETS>                            15,865,614
<PP&E>                                      14,337,246
<DEPRECIATION>                             (5,816,298)
<TOTAL-ASSETS>                              27,265,878
<CURRENT-LIABILITIES>                       10,981,565
<BONDS>                                      2,541,104
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        56,145
<OTHER-SE>                                  13,282,869
<TOTAL-LIABILITY-AND-EQUITY>                27,265,878
<SALES>                                      6,136,942
<TOTAL-REVENUES>                            14,584,721
<CGS>                                        3,018,033
<TOTAL-COSTS>                                9,540,064
<OTHER-EXPENSES>                             6,193,058
<LOSS-PROVISION>                                60,398
<INTEREST-EXPENSE>                           (404,860)
<INCOME-PRETAX>                            (1,552,839)
<INCOME-TAX>                                   590,080
<INCOME-CONTINUING>                          (962,759)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (962,759)
<EPS-BASIC>                                     (0.18)
<EPS-DILUTED>                                   (0.18)